Gender-specific outcomes and treatment responses in elderly HFpEF patients: a comprehensive single-center retrospective study

31 August 2025 (13:15 - 14:00)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Kailei Shi

Huadong Hospital, Shanghai (China)

5 More presentations in this session

Presentation thumbnail

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients

Doctor M. Dagan (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Small left ventricle in patients with heart failure with preserved ejection fraction is associated with higher mortality

Doctor Y. Nakagawa (Kawanishi, JP)

Abstract Slides Video

Presentation thumbnail

Phenogrouping HFpEF trajectories identifies early and end-stage subtypes: a multicentre study using natural language processing

Doctor S. Brown (London, GB)

Abstract Slides Video

Presentation thumbnail

Dapagliflozin versus empagliflozin in patients with heart failure with preserved ejection fraction

Doctor J. Kassab (Dallas, US)

Abstract Slides Video

Presentation thumbnail

Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction

Doctor S. Ratwatte (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

HFpEF issues

The Event

Event poster

ESC Congress 2025

31 August 2025 13:15 CET

You may be interested in

Congress Presentation

Does gender really affect the prognosis of heart failure patients with reduced ejection fraction?

Congress Presentation

Hypertension and mortality risk in heart failure: a gender-specific analysis of HF subtypes

Congress Presentation

Acute myocardial infarction and preserved ejection fraction heart failure: sex differences in echocardiographic parameters

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources